Cargando…
Differentiation syndrome and coagulation disorder — comparison between treatment with oral and intravenous arsenics in pediatric acute promyelocytic leukemia
Realgar-Indigo naturalis formula (RIF), with A(4)S(4) as a major ingredient, is an oral arsenic used in China to treat pediatric acute promyelocytic leukemia (APL). The efficacy of RIF is similar to that of arsenic trioxide (ATO). However, the effects of these two arsenicals on differentiation syndr...
Autores principales: | Luo, Jie-Si, Zhang, Xiao-Li, Huang, Dan-Ping, Chen, Yi-Qiao, Wan, Wu-Qing, Mai, Hui-Rong, Chen, Hui-Qin, Wen, Hong, Liu, Ri-Yang, Chen, Guo-Hua, Li, Yu, Luo, Xue-Qun, Tang, Yan-Lai, Huang, Li-Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261231/ https://www.ncbi.nlm.nih.gov/pubmed/37199788 http://dx.doi.org/10.1007/s00277-023-05270-x |
Ejemplares similares
-
Multicenter randomized trial of arsenic trioxide and Realgar‐Indigo naturalis formula in pediatric patients with acute promyelocytic leukemia: Interim results of the SCCLG‐APL clinical study
por: Yang, Ming‐Hua, et al.
Publicado: (2018) -
Addition of Arsenic Trioxide into Induction Regimens Could Not Accelerate Recovery of Abnormality of Coagulation and Fibrinolysis in Patients with Acute Promyelocytic Leukemia
por: Zhang, Ye, et al.
Publicado: (2016) -
Retinoic Acid and Arsenic for Treating Acute Promyelocytic Leukemia
por: Zhou, Guang-Biao, et al.
Publicado: (2005) -
Importance of monitoring arsenic methylation metabolism in acute promyelocytic leukemia patients receiving the treatment of arsenic trioxide
por: Zheng, Yu, et al.
Publicado: (2021) -
Arsenic Combined With All-Trans Retinoic Acid for Pediatric Acute Promyelocytic Leukemia: Report From the CCLG-APL2016 Protocol Study
por: Zheng, Huyong, et al.
Publicado: (2021)